• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[癌症患者红细胞中的儿茶酚胺]

[Catecholamines in the erythrocytes of cancer patients].

作者信息

Kashulina A P, Sokolova I I, Tereshchenko I P, Popov M I

出版信息

Patol Fiziol Eksp Ter. 1990 Jan-Feb(1):39-40.

PMID:2162023
Abstract

Cytochemical study of catecholamines in red blood cells of lung cancer patients disclosed the specific features of their content depending on the histological structure of the tumor and the advancement of the tumor process. The catecholamine content was lowest in patients with III-IV stage non-oat cell lung carcinoma and highest in patients with apudomas. The indices studied in groups of patients with benign processes in the lungs and with stage I-II non-oat cell carcinoma did not differ essentially from those in the controls.

摘要

对肺癌患者红细胞中儿茶酚胺的细胞化学研究揭示了其含量的特定特征,这些特征取决于肿瘤的组织结构和肿瘤进程的进展。儿茶酚胺含量在Ⅲ - Ⅳ期非燕麦细胞肺癌患者中最低,而在APUD瘤患者中最高。肺部良性病变患者组和Ⅰ - Ⅱ期非燕麦细胞癌患者组所研究的指标与对照组相比,本质上没有差异。

相似文献

1
[Catecholamines in the erythrocytes of cancer patients].[癌症患者红细胞中的儿茶酚胺]
Patol Fiziol Eksp Ter. 1990 Jan-Feb(1):39-40.
2
Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.小细胞肺癌和非小细胞肺癌患者红细胞中谷胱甘肽过氧化物酶、谷胱甘肽-S-转移酶、过氧化氢酶、黄嘌呤氧化酶、铜锌超氧化物歧化酶活性、总谷胱甘肽、一氧化氮和丙二醛水平
Cancer Lett. 2005 Sep 28;227(2):133-9. doi: 10.1016/j.canlet.2004.12.005. Epub 2005 Jan 8.
3
[Specific features of erythrocyte membranes and metabolism in patients with lung cancer].[肺癌患者红细胞膜及代谢的特异性特征]
Vopr Onkol. 2004;50(1):63-7.
4
[Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].[新型肿瘤标志物CYFRA21-1在肺癌患者中的临床应用价值]
Zhonghua Jie He He Hu Xi Za Zhi. 1998 Jan;21(1):26-9.
5
Serum endostatin levels in patients with lung carcinoma.肺癌患者的血清内皮抑素水平。
Rocz Akad Med Bialymst. 2005;50:197-200.
6
[The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients].非小细胞肺癌患者血清中金属蛋白酶9和2的浓度
Pol Merkur Lekarski. 2007 Jun;22(132):539-41.
7
[The estimation of serum concentration of vascular endothelial growth factor in patients with non-small cell lung cancer].[非小细胞肺癌患者血清血管内皮生长因子浓度的测定]
Pol Merkur Lekarski. 2007 Jun;22(132):536-8.
8
[Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].[神经元特异性烯醇化酶(NSE)和鳞状细胞癌抗原(SCC)作为支气管癌诊断中的血清标志物]
Pneumologie. 1990 Nov;44(11):1259-63.
9
Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.癌胚抗原和细胞角蛋白19片段在Ⅰ期非小细胞肺癌患者中的预后价值
Eur J Cardiothorac Surg. 2007 Sep;32(3):435-9. doi: 10.1016/j.ejcts.2007.05.014. Epub 2007 Jul 3.
10
Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.七种肿瘤标志物的最佳组合在非小细胞肺癌患者首次检查时对晚期阶段的预测作用
Anticancer Res. 2001 Jul-Aug;21(4B):3085-92.